Pleiotrophin enhances PDGFB-induced gliomagenesis through increased proliferation of neural progenitor cells Visa övriga samt affilieringar
2016 (Engelska) Ingår i: Oncotarget, E-ISSN 1949-2553, Vol. 7, nr 49, s. 80382-80390Artikel i tidskrift (Refereegranskat) Published
Abstract [en]
Pleiotrophin (PTN) augments tumor growth by increasing proliferation of tumor cells and promoting vascular abnormalization, but its role in early gliomagenesis has not been evaluated. Through analysis of publically available datasets, we demonstrate that increased PTN mRNA expression is associated with amplification of chromosome 7, identified as one of the earliest steps in glioblastoma development. To elucidate the role of PTN in tumor initiation we employed the RCAS/tv-a model that allows glioma induction by RCAS-virus mediated expression of oncogenes in neural progenitor cells. Intracranial injection of RCAS-PTN did not induce glioma formation when administrated alone, but significantly enhanced RCAS-platelet derived growth factor (PDGF) B-induced gliomagenesis. PTN co-treatment augmented PDGFBinduced Akt activation in neural progenitor cells in vitro, and enhanced neural sphere size associated with increased proliferation. Our data indicates that PTN expression is associated with chromosome 7 gain, and that PTN enhances PDGFB-induced gliomagenesis by stimulating proliferation of neural progenitor cells.
Ort, förlag, år, upplaga, sidor 2016. Vol. 7, nr 49, s. 80382-80390
Nyckelord [en]
glioma, pleiotrophin, gliomagenesis, tumor initiation, chromosome 7
Nationell ämneskategori
Cancer och onkologi
Identifikatorer URN: urn:nbn:se:gih:diva-7946 DOI: 10.18632/oncotarget.12983 ISI: 000389877500027 OAI: oai:DiVA.org:gih-7946 DiVA, id: diva2:1812650
Forskningsfinansiär Cancerfonden, CAN 2011/862 CAN 2014/832 CAN 2015/1216 Barncancerfonden, PR2013-0107 PR2015-0133 NCp2015-0075 Vetenskapsrådet, 2013-3797 2023-11-162023-11-162025-09-16